Article Information
History
- September 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Joseph A. Ladapo, MD, PhD1,
- John E. McKinnon, MD, MSc2,
- Peter A. McCullough, MD, MPH3 and
- Harvey A. Risch, MD, PhD4,*
- 1Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, CA
- 2Division of Infectious Diseases, Henry Ford Hospital, Detroit, MI
- 3Department of Internal Medicine, Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX
- 4Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT
- ↵*Address for Correspondence Harvey A. Risch, MD, PhD, Yale School of Public Health, 60 College St, PO Box 208034, New Haven, CT 06520-8034, Phone: 203-785-2848 E-mail: harvey.risch{at}yale.edu
Posted September 30, 2020.
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
